Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Assets (2016 - 2025)

STRATA Skin Sciences' Assets history spans 14 years, with the latest figure at $30.7 million for Q3 2025.

  • For Q3 2025, Assets fell 22.0% year-over-year to $30.7 million; the TTM value through Sep 2025 reached $30.7 million, down 22.0%, while the annual FY2024 figure was $34.9 million, 16.87% down from the prior year.
  • Assets for Q3 2025 was $30.7 million at STRATA Skin Sciences, up from $29.5 million in the prior quarter.
  • Across five years, Assets topped out at $55.2 million in Q2 2023 and bottomed at $29.5 million in Q2 2025.
  • The 5-year median for Assets is $45.9 million (2021), against an average of $44.1 million.
  • The largest annual shift saw Assets increased 20.14% in 2022 before it dropped 29.79% in 2024.
  • A 5-year view of Assets shows it stood at $46.6 million in 2021, then grew by 12.19% to $52.3 million in 2022, then decreased by 19.62% to $42.0 million in 2023, then fell by 16.87% to $34.9 million in 2024, then fell by 12.06% to $30.7 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Assets are $30.7 million (Q3 2025), $29.5 million (Q2 2025), and $33.0 million (Q1 2025).